2024

Gupta, S. D. et al. (2024) Effects of sacubitril/valsartan according to background beta-blocker therapy in patients with heart failure and reduced ejection fraction: Insights from PARADIGM-HF. European Journal of Heart Failure, (doi: 10.1002/ejhf.3515) (PMID:39563094) (Early Online Publication)

Jhund, P. S. et al. (2024) Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis. Lancet, 404(10458), pp. 1119-1131. (doi: 10.1016/S0140-6736(24)01733-1) (PMID:39232490)

Yang, M. et al. (2024) Dapagliflozin and quality of life measured using the EuroQol 5-Dimension questionnaire in patients with HFrEF and HFmrEF/HFpEF. European Journal of Heart Failure, 26(7), pp. 1524-1538. (doi: 10.1002/ejhf.3263) (PMID:38700986)

Curtain, J. P. et al. (2024) Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF. European Journal of Heart Failure, 26(6), pp. 1383-1392. (doi: 10.1002/ejhf.3290) (PMID:38741283)

Kondo, T. et al. (2024) Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF. Journal of the American College of Cardiology, 83(20), pp. 1973-1986. (doi: 10.1016/j.jacc.2024.03.385) (PMID:38537918)

Carrasco-Marín, F. et al. (2024) Adherence to dietary recommendations by socioeconomic status in the United Kingdom biobank cohort study. Frontiers in Nutrition, 11, 1349538. (doi: 10.3389/fnut.2024.1349538)

McDowell, K. et al. (2024) Prognostic models for mortality and morbidity in heart failure with preserved ejection fraction. JAMA Cardiology, 9(5), 457. (doi: 10.1001/jamacardio.2024.0284) (PMID:38536153)

Borumandnia, N., Rostami, M., Talebi, A. and Alavimajd, H. (2024) The impact of vitamin D changes during pregnancy on the development of maternal adverse events: A random forest analysis. BMC Pregnancy and Childbirth, 24, 125. (doi: 10.1186/s12884-024-06294-5) (PMID:38341546) (PMCID:PMC10858460)

2023

Boonpor, J. et al. (2023) Associations and predictive performance of eleven anthropometric measures with incident type 2 diabetes: a prospective cohort study from the UK Biobank. Obesity, 31(10), pp. 2648-2657. (doi: 10.1002/oby.23849) (PMID:37724055)

Shakhssalim, N., Talebi, A., Pahlevan‐Fallahy, M.‐T., Sotoodeh, K., Alavimajd, H., Borumandnia, N. and Taheri, M. (2023) Lifestyle and occupational risks assessment of bladder cancer using machine learning‐based prediction models. Cancer Reports, 6(9), e1860. (doi: 10.1002/cnr2.1860) (PMID:37403801) (PMCID:PMC10480417)

Boonpor, J. et al. (2023) Association between walking pace and incident type 2 diabetes by adiposity levels – a prospective cohort study from the UK Biobank. Diabetes, Obesity and Metabolism, 25(7), pp. 1900-1910. (doi: 10.1111/dom.15053) (PMID:36951683)

Jhund, P. S. et al. (2023) Effect of dapagliflozin on total heart failure events in patients with heart failure with mildly reduced or preserved ejection fraction. A prespecified analysis of the DELIVER trial. JAMA Cardiology, 8(6), pp. 554-563. (doi: 10.1001/jamacardio.2023.0711) (PMID:37099283) (PMCID:PMC10134044)

Talebi, A., Celis‑Morales, C. , Borumandnia, N., Abbasi, S., Pourhoseingholi, M. A., Akbari, A. and Yousefi, J. (2023) Predicting metastasis in gastric cancer patients: machine learning-based approaches. Scientific Reports, 13, 4163. (doi: 10.1038/s41598-023-31272-w) (PMID:36914697) (PMCID:PMC10011363)

2022

Kondo, T. et al. (2022) Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation. European Heart Journal, 43(42), pp. 4469-4479. (doi: 10.1093/eurheartj/ehac487) (PMID:36017729) (PMCID:PMC9637422)

Articles

Gupta, S. D. et al. (2024) Effects of sacubitril/valsartan according to background beta-blocker therapy in patients with heart failure and reduced ejection fraction: Insights from PARADIGM-HF. European Journal of Heart Failure, (doi: 10.1002/ejhf.3515) (PMID:39563094) (Early Online Publication)

Jhund, P. S. et al. (2024) Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis. Lancet, 404(10458), pp. 1119-1131. (doi: 10.1016/S0140-6736(24)01733-1) (PMID:39232490)

Yang, M. et al. (2024) Dapagliflozin and quality of life measured using the EuroQol 5-Dimension questionnaire in patients with HFrEF and HFmrEF/HFpEF. European Journal of Heart Failure, 26(7), pp. 1524-1538. (doi: 10.1002/ejhf.3263) (PMID:38700986)

Curtain, J. P. et al. (2024) Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF. European Journal of Heart Failure, 26(6), pp. 1383-1392. (doi: 10.1002/ejhf.3290) (PMID:38741283)

Kondo, T. et al. (2024) Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF. Journal of the American College of Cardiology, 83(20), pp. 1973-1986. (doi: 10.1016/j.jacc.2024.03.385) (PMID:38537918)

Carrasco-Marín, F. et al. (2024) Adherence to dietary recommendations by socioeconomic status in the United Kingdom biobank cohort study. Frontiers in Nutrition, 11, 1349538. (doi: 10.3389/fnut.2024.1349538)

McDowell, K. et al. (2024) Prognostic models for mortality and morbidity in heart failure with preserved ejection fraction. JAMA Cardiology, 9(5), 457. (doi: 10.1001/jamacardio.2024.0284) (PMID:38536153)

Borumandnia, N., Rostami, M., Talebi, A. and Alavimajd, H. (2024) The impact of vitamin D changes during pregnancy on the development of maternal adverse events: A random forest analysis. BMC Pregnancy and Childbirth, 24, 125. (doi: 10.1186/s12884-024-06294-5) (PMID:38341546) (PMCID:PMC10858460)

Boonpor, J. et al. (2023) Associations and predictive performance of eleven anthropometric measures with incident type 2 diabetes: a prospective cohort study from the UK Biobank. Obesity, 31(10), pp. 2648-2657. (doi: 10.1002/oby.23849) (PMID:37724055)

Shakhssalim, N., Talebi, A., Pahlevan‐Fallahy, M.‐T., Sotoodeh, K., Alavimajd, H., Borumandnia, N. and Taheri, M. (2023) Lifestyle and occupational risks assessment of bladder cancer using machine learning‐based prediction models. Cancer Reports, 6(9), e1860. (doi: 10.1002/cnr2.1860) (PMID:37403801) (PMCID:PMC10480417)

Boonpor, J. et al. (2023) Association between walking pace and incident type 2 diabetes by adiposity levels – a prospective cohort study from the UK Biobank. Diabetes, Obesity and Metabolism, 25(7), pp. 1900-1910. (doi: 10.1111/dom.15053) (PMID:36951683)

Jhund, P. S. et al. (2023) Effect of dapagliflozin on total heart failure events in patients with heart failure with mildly reduced or preserved ejection fraction. A prespecified analysis of the DELIVER trial. JAMA Cardiology, 8(6), pp. 554-563. (doi: 10.1001/jamacardio.2023.0711) (PMID:37099283) (PMCID:PMC10134044)

Talebi, A., Celis‑Morales, C. , Borumandnia, N., Abbasi, S., Pourhoseingholi, M. A., Akbari, A. and Yousefi, J. (2023) Predicting metastasis in gastric cancer patients: machine learning-based approaches. Scientific Reports, 13, 4163. (doi: 10.1038/s41598-023-31272-w) (PMID:36914697) (PMCID:PMC10011363)

Kondo, T. et al. (2022) Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation. European Heart Journal, 43(42), pp. 4469-4479. (doi: 10.1093/eurheartj/ehac487) (PMID:36017729) (PMCID:PMC9637422)